Accuray Incorporated Revenue Growth Rates (ARAY), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Accuray Incorporated  (NASDAQ: ARAY)
 

ARAY's Revenue Growth by Quarter and Year

Accuray Incorporated's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARAY Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June 100.92
3rd Quarter March 104.29
2nd Quarter December 102.07
1st Quarter September 93.55
FY 400.83

ARAYs Annual Revenue
Accuray Incorporated's Revenue in the fiscal year 2026 $ 401.95 millions
Accuray Incorporated's Revenue in the fiscal year 2025 $ 457.97 millions
Accuray Incorporated's Revenue in the fiscal year 2024 $ 445.92 millions
Accuray Incorporated's Revenue in the fiscal year 2023 $ 446.96 millions
Accuray Incorporated's Revenue in the fiscal year 2022 $ 429.91 millions




ARAY Revenue fourth quarter 2025 Y/Y Growth Comment
Accuray Incorporated reported decline in Revenue in the fourth quarter 2025 by -21.14% to $ 100.92 millions, from the same quarter in 2024.
The contraction in the fourth quarter 2025 Accuray Incorporated's Revenue compares unfavorably to the Company's average Revenue growth of 2.52%.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 138 other companies have achieved higher Revenue growth. While Accuray Incorporated' s Revenue fall of -21.14% ranks overall at the positon no. 2606 in the fourth quarter 2025.


ARAY Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter June -21.14 % -4.7 % 13.53 % 7.52 %
3rd Quarter March -7.4 % 11.44 % -14.39 % 23.26 %
2nd Quarter December -11.93 % 8.41 % -6.85 % -1.31 %
1st Quarter September -7.81 % -1.95 % 7.25 % -10.19 %
FY   -12.48 % 2.74 % -0.41 % -

Financial Statements
Accuray Incorporated's fourth quarter 2025 Revenue $ 100.92 millions ARAY's Income Statement
Accuray Incorporated's fourth quarter 2024 Revenue $ 127.98 millions Quarterly ARAY's Income Statement


ARAY Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter June -3.23 % 13.63 % 32.87 % 0.19 %
3rd Quarter March 2.17 % -2.81 % -5.45 % 2.88 %
2nd Quarter December 9.11 % 14.21 % 3.3 % 18.93 %
1st Quarter September -26.9 % -24.44 % -12.51 % -12.3 %
FY (Year on Year)   -12.48 % 2.74 % -0.41 % -


Back to ARAY Growth rate Comparisons >> Back to ARAY Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #374
Overall #2606

Revenue Y/Y Growth Statistics
High Average Low
21.07 % 2.52 % -12.48 %
(Sep 30 2014)   (Jun 30 2026)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #374
Overall #2606
Revenue Y/Y Growth Statistics
High Average Low
21.07 % 2.52 % -12.48 %
(Sep 30 2014)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Accuray Incorporated's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
42.5 % 2.61 % -26.9 %
(Dec 31 2010)  


ARAY's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2025 Accuray Incorporated disclosed fall in Revenue from the third quarter by -3.23% to $ 100.92 millions, from $ 104.29 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2025 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 88 other companies have achieved higher Revenue quarter on quarter growth. While Accuray Incorporated's Revenue growth quarter on quarter, overall rank is 2249.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #89
Healthcare Sector #286
Overall #2249
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #89
Healthcare Sector #286
Overall #2249
Revenue Q/Q Growth Statistics
High Average Low
42.5 % 2.61 % -26.9 %
(Dec 31 2010)  


ARAY's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2025 Accuray Incorporated disclosed fall in Revenue from the third quarter by -3.23% to $ 100.92 millions, from $ 104.29 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2025 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 88 other companies have achieved higher Revenue quarter on quarter growth. While Accuray Incorporated's Revenue growth quarter on quarter, overall rank is 2249.


Accuray Incorporated's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 400.83 $ 427.89 $ 436.23 $ 450.05 $ 457.97
Y / Y Revenue Growth (TTM) -12.48 % -7.84 % -3.64 % 1.42 % 2.74 %
Year on Year Revenue Growth Overall Ranking # 2213 # 2123 # 955 # 1909 # 2460
Seqeuential Revenue Change (TTM) -6.32 % -1.91 % -3.07 % -1.73 % -1.36 %
Seq. Revenue Growth (TTM) Overall Ranking # 2606 # 1990 # 736 # 1959 # 2311


Cumulative Revenue growth Comment
Accuray Incorporated's cumulative 12 months Revenue continue to fall, but on the faster rate at -12.48% year on year, at Jun 30 2026 compare to the -7.84% decrease at Mar 31 2026. If the Accuray Incorporated's fiscal year would end at Jun 30 2026, annual Revenue would be $401 millions.

In the Healthcare sector 320 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2123 to 2213.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 321
Overall # 2213

Revenue TTM Y/Y Growth Statistics
High Average Low
21.07 %
 2.52 %
-12.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 374
S&P 500 # 2606
Cumulative Revenue growth Comment
Accuray Incorporated's cumulative 12 months Revenue continue to fall, but on the faster rate at -12.48% year on year, at Jun 30 2026 compare to the -7.84% decrease at Mar 31 2026. If the Accuray Incorporated's fiscal year would end at Jun 30 2026, annual Revenue would be $401 millions.

In the Healthcare sector 320 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2123 to 2213.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 321
Overall # 2213

Revenue TTM Y/Y Growth Statistics
High Average Low
21.07 %
2.52 %
-12.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 374
S&P 500 # 2606




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ARAY's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Accuray Incorporated Revenue Growth Rates (ARAY), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Accuray Inc (CIK 1138723).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-029098
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Accuray Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.